BrainAurora Medical Technology Limited released its Monthly Return for the period ended 31 August 2026, reporting no changes to either its authorised or issued share capital.

The company’s authorised share capital remained at 500.00 billion ordinary shares with a par value of USD 0.0000001 each, equivalent to USD 0.05 million. Issued share capital was unchanged at 1.36 billion ordinary shares, and BrainAurora held no treasury shares at month-end.

BrainAurora affirmed that it continued to meet the Hong Kong Main Board’s minimum public-float requirement of 25 % of issued shares.

No share options, warrants, convertible instruments, Hong Kong depositary receipts or other equity-issuing arrangements were outstanding or initiated during the month.

Overall, BrainAurora’s capital structure and share count were steady through August 2026, underscoring a period of stability in the company’s equity profile.